OPKO Health (OPK) Tops Q1 EPS by 7c
Tweet
Share
E-mail
Get Alerts OPK Hot Sheet
Price: $1.64 +1.86%
EPS Growth %: -333.3%
Financial Fact:
Net loss attributable to common Shareholders: -14.98M
Today's EPS Names:
VIVO, BIOX, PMCB, More
EPS Growth %: -333.3%
Financial Fact:
Net loss attributable to common Shareholders: -14.98M
Today's EPS Names:
VIVO, BIOX, PMCB, More
Join SI Premium – FREE
OPKO Health (NASDAQ: OPK) reported Q1 EPS of ($0.02), $0.07 better than the analyst estimate of ($0.09). Revenue for the quarter came in at $237.6 million versus the consensus estimate of $193.35 million.
For earnings history and earnings-related data on OPKO Health (OPK) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- EU proposes to curb Airbnb and short-term rentals amid housing shortage
- Goldman Sachs Downgrades Schindler Holding AG (SCHN:SW) (SHLAF) to Sell
- ICICI Bank (ICICIBC:IN) (IBN) PT Raised to INR2,000 at Goldman Sachs
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
